| AD | Alzheimer’s disease |
| ALS | amyotrophic lateral sclerosis |
| AMPA | α-amino-3 hydroxy-5-methyl-4-isoxazolepropionic acid receptor |
| AMPK | adenosine monophosphate-activated protein kinase |
| ANT | adenine nucleotide translocase |
| APAF-1 | apoptosis protease-activating factor-1 |
| ASC | adaptor protein |
| ATP | adenosine triphosphate |
| Aβ | amyloid beta-peptide |
| BAP31 | B-cell receptor-associated protein 31 |
| BDNF | brain-derived neurotrophic factor |
| BER | Base excision repair |
| β/cAMP | β-adrenergic signalling |
| Ca2+ | Calcium |
| CAMKII | Ca2+/calmodulin-dependent protein kinase |
| CAT | Catalase |
| CDKs | cyclin-dependent kinases |
| CICR | Ca2+-induced Ca2+ release |
| CHCHD2 | coiled-coil-helix-coiled-coil-helix domain containing 2 |
| CHCHD10 | coiled-coil-helix-coiled-coil-helix domain-containing 10 |
| CREB | cAMP response element-binding protein |
| Cybrid | cytoplasmatic hybrids |
| CypD | cyclophilin D |
| CytC | cytochrome C |
| Drp1 | dynamin-related protein 1 |
| EMRE | essential MCU regulator |
| eNOS | endothelial NOS |
| ER | endoplasmic reticulum |
| ERKs | extracellular signal-regulated kinases |
| Fis1 | mitochondrial fission 1 |
| FUS | fused in sarcoma |
| FZ | frizzled receptor |
| GABA | γ-aminobutyric acid |
| GPx | glutathione peroxidase |
| GSH | Glutathione |
| Grp75 | mitochondrial chaperone glucose-regulated protein 75 |
| GSK3β | glycogen synthase kinase-3β |
| H2O2 | hydrogen peroxide |
| HD | Huntington’s disease |
| HKII | hexokinase II |
| HTT | Huntingtin |
| IKK | IkB kinase |
| IL-18 | interleukin 18 |
| IL-1β | interleukin 1β |
| IL-6 | interleukin 6 |
| IMM | inner mitochondrial membrane |
| INF2 | inverted formin 2 |
| IP3R | inositol triphosphate receptor |
| IR | insulin receptor |
| IRS | insulin receptor substrate |
| JNK | c-Jun N-terminal kinase |
| LRP5/6 | low-density lipoprotein receptor-related protein 5/6 |
| LRRK | Leucine Rich Repeat Kinase 2 |
| LTP | long-term potentiation |
| MAM | mitochondria associated membranes |
| MAPK | mitogen activated protein kinases |
| MCI | mild cognitive impairment |
| MCU | mitochondrial Ca2+ uniporter |
| MCUb | Mitochondrial Calcium Uniporter Dominant Negative Subunit Beta |
| MCUR1 | MCU regulator 1 |
| MFF | mitochondrial fission factor |
| MFN | Mitofusin |
| MFN1 | mitofusin protein 1 |
| MFN2 | mitofusin protein 2 |
| MICU1 | mitochondrial calcium uptake 1 |
| MICU2 | mitochondrial calcium uptake 2 |
| MiD49 | mitochondrial dynamic protein 49 |
| MiD50 | mitochondrial dynamic protein 50 |
| Miro | Mitochondrial Rho GTPase |
| MNRR1 | Mitochondria Nuclear Retrograde Regulator 1 |
| mPTP | mitochondrial permeability transition pore |
| MPTP | 1-methyl4-phenyl-1,2,3,4-tetrahydropyridine |
| MRC | mitochondrial respiratory chain |
| mtDNA | mitochondrial DNA |
| mtNOS | mitochondrial NOS |
| mTOR | mechanistic target of rapamycin kinase |
| Myo19 | myosin19 |
| NAD+/NADH | nicotinamide adenine dinucleotide |
| NCLX | Li+-permeable Na+/Ca2+ exchanger |
| NFAT | nuclear factor of activated T-cells |
| NF-κB | nuclear factor kappa-light-chain-enhancer of activated B cells |
| NLRP3 | Nod-like receptor 3 |
| NMDAR | N-methyl-D-aspartate receptor |
| nNOS | neuronal NOS |
| NO | Nitric oxide |
| NOS | constitutive NO-synthase |
| NRF1 | nuclear respiratory factor 1 |
| NRF2 | nuclear respiratory factor 2 |
| O2·− | superoxide anion |
| OH.− | hydroxyl radical |
| OMM | outer mitochondrial membrane |
| ONOO− | Peroxynitrite |
| OPA1 | protein optic atrophy 1 |
| p38α | p38 mitogen-activated protein kinase alpha |
| PACS-2 | phosphofurin acidic cluster sorting protein 2 |
| PD | Parkinson’s disease |
| PGC-1α | peroxisome proliferator-activated receptor-γ (PPARγ) coactivator-1α |
| PGC1β | peroxisome proliferator-activated receptor gamma coactivator 1-beta |
| PI3K | phospho-inositol-3 kinase |
| PINK1 | PTEN-induced kinase 1 |
| PIP | phosphatidylinositol phosphate |
| PKC | protein kinase C |
| PRC | PGC-related coactivator |
| PS2 | presenilin 2 |
| pS302 | phosphorylation of insulin receptor at serine-302 |
| pS307 | phosphorylation of insulin receptor at serine-307 |
| PTPIP51 | tyrosine phosphatase-interacting protein-51 |
| ROS | reactive oxygen species |
| RyR | ryanodine receptor |
| SERCA | sarco/endoplasmic reticulum Ca2+-ATPase |
| SIRT | silent mating type information regulation 2 homolog |
| SOC | store-operated Ca2+ channel |
| SOCE | store operated Ca2+ entry |
| SOCS | suppressor cytokine signalling |
| SOD | antioxidant enzymes superoxide dismutase |
| SOD1 | Cu/Zn superoxide dismutase 1 |
| SLC25A23 | solute carrier 25A23 |
| STIM | stromal interaction molecule |
| T2D | type 2 diabetes |
| SNPC | substantia nigra pars compacta |
| SNPH | Syntaphilin |
| TCA | tricarboxylic acid cycle |
| TARDBP/TDP-43 | transactive response DNA binding protein 43 |
| TFAM | mitochondrial transcription factor A |
| TFB1M | cofactor mitochondrial transcription factor B |
| TH | thyroid hormone |
| TNF-α | tumor necrosis factor α |
| TOMM 40 | Translocase of the OMM 40 |
| TRAK | trafficking kinesin protein |
| TRP | transient receptor potential |
| VAPB | vesicle-associated membrane protein-B |
| VDAC | voltage dependent anion channel 1 |
| VGCC | voltage-gated Ca2+ channels |
| WISP3/CCN6 | Wnt-induced signaling protein 3 |
| Wnt | Wnt signaling pathway |
| ΔΨm | mitochondrial membrane potential. |